|
Feb 21
|
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage
|
|
Feb 21
|
Hims & Hers Stock Plummets. The Wegovy Shortage Is Over.
|
|
Feb 21
|
Hims & Hers Stock Drops as FDA Says Ozempic and Wegovy No Longer in Short Supply
|
|
Feb 21
|
Is Eli Lilly and Company (LLY) the Best Non-Tech Stock to Buy Now for Long Term?
|
|
Feb 21
|
Eli Lilly (LLY): Buy, Sell, or Hold Post Q4 Earnings?
|
|
Feb 20
|
Why Hims & Hers Stock Dropped Today
|
|
Feb 20
|
Eli Lilly and Company (LLY): Among the Best Long-Term Stocks to Buy According to Ken Fisher
|
|
Feb 20
|
Eli Lilly bets big on weight-loss pill with $550 million inventory stockpile
|
|
Feb 20
|
Eli Lilly wants to use its weight loss drug windfall to fight Alzheimer's and hearing loss
|
|
Feb 20
|
Eli Lilly Shifts Focus from GLP-1 Success to Neurological Breakthroughs
|
|
Feb 20
|
Don't Overlook Lilly (LLY) International Revenue Trends While Assessing the Stock
|
|
Feb 20
|
These stocks are now among the S&P 500's top contributors
|
|
Feb 20
|
Lilly’s former M&A chief scours the landscape for potential deals as Immunocore’s new CFO
|
|
Feb 19
|
'Health insurance companies are always going to need a PBM': CVS president Prem Shah
|
|
Feb 19
|
Eli Lilly and Company (LLY) Slid as its GLP-1 Revenue Missed Expectations
|
|
Feb 19
|
Digging Into What Hershey and Eli Lilly Told Investors
|
|
Feb 19
|
GLP-1RAs and opioid use disorder: a new frontier in addiction treatment
|
|
Feb 19
|
Next generation weight loss drugs aim to save muscle
|
|
Feb 19
|
Merck, Lilly launch manufacturing R&D consortium to help ‘bolster’ U.S. production
|
|
Feb 19
|
What Top-Performing Healthcare Funds Are Buying Now
|